CSPG4 as a target for the specific killing of triple-negative breast cancer cells by a recombinant SNAP-tag-based antibody-auristatin F drug conjugate.
Neelakshi MungraFleury Augustin Nsole BitegheZaria MalindiAllan M HuysamenMaryam KaraanNatasha S HardcastleRubina BunjunShivan ChettyKrupa NaranDirk LangWolfgang F RichterRoger HunterStefan BarthPublished in: Journal of cancer research and clinical oncology (2023)
This research underscores the applicability of SNAP-tag in the unambiguous generation of homogeneous and pharmaceutically relevant immunoconjugates that could potentially be instrumental in the management of a daunting disease like TNBC.